SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade (vol 9, pg 304, 2019)

被引：0

作者：

Zhao, Mingxia ^{[1
]}

Guo, Wenjie ^{[1
]}

Wu, Yuanyuan ^{[2
]}

Yang, Chenxi ^{[1
]}

Zhong, Liang ^{[3
]}

Deng, Guoliang ^{[1
]}

Zhu, Yuyu ^{[1
]}

Liu, Wen ^{[1
]}

Gu, Yanhong ^{[4
]}

Lu, Yin ^{[2
]}

Kong, Lingdong ^{[1
]}

Meng, Xiangbao ^{[1
,3
]}

Xu, Qiang ^{[1
]}

Sun, Yang ^{[1
]}

机构：

[1] Nanjing Univ, Sch Life Sci, Dept Biotechnol & Pharmaceut Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Peoples R China

[2] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing 210023, Peoples R China

[3] Peking Univ, Sch Pharmaceut Sci, Dept Chem Biol, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China

[4] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing 210029, Peoples R China

来源：

关键词：

D O I：

10.1016/j.apsb.2024.12.023

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2810 / 2812

页数：3